PATENT CLAIM ANALYSIS

Application Number: 16040640
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["424", "489000"]

Abstract:
The disclosure provides nanoparticles of indirubin and methods of making and using these particles for the treatment of cancer, neurodegenerative disorders and inflammatory diseases. The effective average particle size of the nanoparticles is less than 2000 nm.

Claim (Index 28):
A method of treating an inflammatory disease in a subject in need thereof comprising administering an effective amount of the nanoparticulate indirubin composition of  claim 1 .

Metadata:
- Claim Count in Document: 44.0
- Percentile: 95.0
- Lexical Diversity: 1.29032
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14573212', '13110647', '11402264', '11802542', '10784900']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6804128436702136
- 35 USC 102 Novelty (BERT): 0.5457268105155922
- Combined Prediction Score: 0.6669442403547514
- Mean Citation Score: 259.352626
- Max Citation Score: 397.74222
- Similarity Product: 237.069850235002

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test